clinical trial · NCT06229353
Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
University of Alabama at Birmingham·—·terminated·n = 34
Human Papilloma VirusGardasil 9
brief summary
To determine if the emergency department (ED) setting offers a viable space for improving HPV vaccination coverage among 18 to 45-year-old adults who have not yet received human papilloma virus (HPV) vaccination or who did not complete the vaccine series. This study will develop, pilot and evaluate an ED-based HPV vaccination protocol and program for ED patients aged 18-26 (for whom catch-up HPV vaccination is routinely recommended by the CDC) and separately for patients aged 27-45 (for whom it may be recommended under shared decision making, SDM).
started
Aug 8, 2024
primary completion
Jul 30, 2025
completion
Jul 30, 2025
last updated
Apr 20, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol